Combining radiotherapy with CAR-T cell therapy for solid tumors: Challenges, mechanisms, and future directions

Area of Science:

• Oncology
• Immunotherapy
• Radiation Oncology

Background:

• Chimeric antigen receptor (CAR)-T cell therapy is effective against blood cancers but faces challenges in solid tumors.
• Radiotherapy, a standard solid tumor treatment, possesses immunomodulatory effects.
• Combining CAR-T cell therapy with radiotherapy may overcome limitations for solid tumor treatment.

Purpose of the Study:

• To review the theoretical basis and research progress of combining CAR-T cell therapy and radiotherapy.
• To explore critical factors for optimizing combined treatment strategies.
• To offer new perspectives on future research directions in this field.

Main Methods:

• Review of theoretical foundations of CAR-T cell therapy and radiotherapy.
• Analysis of preclinical and clinical research progress on combined treatments.
• Exploration of key factors influencing combined therapy efficacy.

Main Results:

• The combination of CAR-T cell therapy and radiotherapy presents a promising strategy for solid tumors.
• Key factors such as radiation dose, mode, type, timing, and scheduling are crucial for treatment success.
• Current research highlights the potential of this combination, with ongoing investigations into optimization.

Conclusions:

• Combined CAR-T cell therapy and radiotherapy holds significant potential for improving solid tumor treatment.
• Careful consideration of treatment parameters is essential for maximizing therapeutic benefits.
• Further research is needed to address remaining challenges and refine combined treatment protocols.